Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAJA3 encodes a member of the DNAJ/Hsp40 protein family, acting as a molecular chaperone that stimulates Hsp70 ATPase activity. It plays critical roles in protein folding, mitochondrial function, apoptosis regulation, tumor suppression, and antiviral response. It exists as long (pro-apoptotic) and short (anti-apoptotic) isoforms, influencing mitochondrial dynamics and cell fate decisions. Its interactions with oncogenic proteins and tumor suppressors highlight its significance in cancer biology.
Modulates Hsp70 ATPase activity, regulates mitochondrial dynamics and apoptosis pathways, interacts with oncogenic proteins and tumor suppressors, induces autophagy for antiviral defense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family (Hsp40) member A3 (DNAJA3).